Human immunodeficiency virus glycoproteins 160 and 41 alter sleep and brain temperature of rats.
Sleep is altered during all stages at which it has been recorded during chronic human immunodeficiency virus (HIV) infection, including the long latent phase before the development of AIDS; the mechanisms for such alterations are not known. The HIV envelope glycoprotein (gp) 120 alters sleep of rats in a manner somewhat similar to the alterations that occur in humans infected with HIV. To further determine which components of the virus may be responsible for altered behavior, we administered centrally into rats prior to dark onset recombinant HIV gp160 or gp41. Both glycoproteins increased non-rapid eye movements sleep, fragmented sleep, altered slow frequency components of the electroencephalogram, and induced modest febrile responses. These results complement and extend those previously obtained after gp120; HIV envelope glycoproteins are capable of altering sleep.
Gemma
C
C
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston 77555-0431, USA.
Opp
M R
MR
D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D001143:Arousal / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature; D001921:Brain / Q000276:immunology / Q000821:virology*; D003700:Delta Rhythm; D019302:HIV Envelope Protein gp160 / Q000494:pharmacology*; D015700:HIV Envelope Protein gp41 / Q000494:pharmacology*; D007276:Injections, Intraventricular; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012895:Sleep, REM / Q000187:drug effects*
D000956:Antigens, Viral; D019302:HIV Envelope Protein gp160; D015700:HIV Envelope Protein gp41